brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastické činidlá - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
cresemba
basilea pharmaceutica deutschland gmbh - isavuconazole - aspergilóza - cresemba je indikovaný u dospelých na liečbu:invázne aspergillosismucormycosis u pacientov, pre ktorých amphotericin b je inappropriateconsideration by mala byť oficiálne usmernenie o vhodnom používaní protiplesňové agentov.
timonil retard 150 mg
desitin arzneimitttel gmbh, nemecko - karbamazepín - 21 - antiepileptica, anticonvulsiva
parvaxor 40 mg/10 mg
egis pharmaceuticals plc, maďarsko - atorvastatín a perindopril - 58 - hypotensiva
parvaxor 10 mg/10 mg
egis pharmaceuticals plc, maďarsko - atorvastatín a perindopril - 58 - hypotensiva
parvaxor 20 mg/5 mg
egis pharmaceuticals plc, maďarsko - atorvastatín a perindopril - 58 - hypotensiva
parvaxor 10 mg/5 mg
egis pharmaceuticals plc, maďarsko - atorvastatín a perindopril - 58 - hypotensiva
timonil retard 600 mg
desitin arzneimitttel gmbh, nemecko - karbamazepín - 21 - antiepileptica, anticonvulsiva
timonil retard 300 mg
desitin arzneimitttel gmbh, nemecko - karbamazepín - 21 - antiepileptica, anticonvulsiva
zocor 10 mg
n.v. organon, holandsko - simvastatín - 31 - hypolipidaemica